Prolyl-4-hydroxylase subunit 2 (P4HA2), a collagen modification enzyme, exhibits higher transcriptional levels in glioma samples compared to normal brain tissue, correlating with glioma grading and patient survival [73]. The gene discussed is P4HA2; the disease is central nervous system cancer.